Cargando…

Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study

BACKGROUND/AIMS: Our study aimed to evaluate the long-term outcomes and risk factors for relapse after anti-tumor necrosis factor (TNF)-α cessation in inflammatory bowel disease (IBD) patients because they are not well established. METHODS: A retrospective multicenter cohort study was conducted invo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Joo Hye, Kang, Eun Ae, Park, Soo-Kyung, Hong, Sung Noh, Kim, You Sun, Bang, Ki Bae, Kim, Kyeong Ok, Lee, Hong Sub, Kang, Sang-Bum, Shin, Seung Yong, Song, Eun Mi, Im, Jong Pil, Choi, Chang Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444111/ https://www.ncbi.nlm.nih.gov/pubmed/33767028 http://dx.doi.org/10.5009/gnl20233

Ejemplares similares

Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?
por: Kim, Byungsoo, et al.
Publicado: (2019)

Factors Contributing to the Preference of Korean Patients with Crohn’s Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)
por: Kim, Eun Soo, et al.
Publicado: (2016)

Patients with Inflammatory Bowel Disease Are at an Increased Risk of Parkinson’s Disease: A South Korean Nationwide Population-Based Study
por: Park, Seona, et al.
Publicado: (2019)

Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease
por: Koh, Seong-Joon, et al.
Publicado: (2023)

Discontinuation of Azathioprine could be considered in pediatric patients with Crohn’s disease who have sustained clinical and deep remission
por: Jeong, Tae Jong, et al.
Publicado: (2022)

Old Age at Diagnosis Is Associated With Favorable Outcomes in Korean Patients With Inflammatory Bowel Disease
por: Choi, Jae Hyuk, et al.
Publicado: (2015)

Association between Fecal Calprotectin and Mucosal Healing in Pediatric Patients with Crohn’s Disease Who Have Achieved Sustained Clinical Remission with Anti-Tumor Necrosis Factor Agents
por: Lee, Yoo Min, et al.
Publicado: (2022)

Risk Factors for Postoperative Recurrence in Korean Patients with Crohn’s Disease
por: Kim, Sung Bae, et al.
Publicado: (2020)

The Efficiency of Intravenous Iron Therapy in Korean Inflammatory Bowel Disease Patients
por: Kim, Kyeong Ok
Publicado: (2016)

Prevalence and changes in chronic diseases among South Korean farmers: 1998 to 2005
por: Cha, Eun Shil, et al.
Publicado: (2009)

Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)
por: Lee, Jung Hoon, et al.
Publicado: (2007)

Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
por: Chaparro, María, et al.
Publicado: (2019)

Duration of remission phase of 36 Korean patients with glossopharyngeal neuralgia
por: Kang, Myong-Soo, et al.
Publicado: (2013)

Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
por: Kang, Eun Ae, et al.
Publicado: (2022)

Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease
por: Lee, Ji Min, et al.
Publicado: (2022)

Increased Risk of Diabetes in Inflammatory Bowel Disease Patients: A Nationwide Population-Based Study in Korea
por: Kang, Eun Ae, et al.
Publicado: (2019)

Increased monocyte abundance as a marker for relapse after discontinuation of biologics in inflammatory bowel disease with deep remission
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Effect of Probiotics on Symptoms in Korean Adults with Irritable Bowel Syndrome
por: Hong, Kyoung Sup, et al.
Publicado: (2009)

Changes in the Intestinal Microbiota of Patients with Inflammatory Bowel Disease with Clinical Remission during an 8-Week Infliximab Infusion Cycle
por: Seong, Gyeol, et al.
Publicado: (2020)

Metabolic Syndrome and Chronic Kidney Disease in an Adult Korean Population: Results from the Korean National Health Screening
por: Kang, Yong Un, et al.
Publicado: (2014)

Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children’s immunity
por: Lee, Ko Eun, et al.
Publicado: (2019)

Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease
por: Gelbenegger, Georg, et al.
Publicado: (2022)

Proteinuria Is Associated with the Development of Crohn’s Disease: A Nationwide Population-Based Study
por: Park, Seona, et al.
Publicado: (2021)

Naturally Occurring Mutations in the Nonstructural Region 5B of Hepatitis C Virus (HCV) from Treatment-Naïve Korean Patients Chronically Infected with HCV Genotype 1b
por: Kim, Dong-Won, et al.
Publicado: (2014)

Accelerated Disease Progression after Discontinuation of Sorafenib in a Patient with Metastatic Papillary Thyroid Cancer
por: Yun, Kyung-Jin, et al.
Publicado: (2014)

Prevalence and mortality of congenital heart disease in Korean adults
por: Jang, Shin Yi, et al.
Publicado: (2018)

Depression, Anxiety, Related Risk Factors and Cognitive Distortion in Korean Patients with Inflammatory Bowel Disease
por: Song, Jun Ho, et al.
Publicado: (2020)

Validation of the ECOS-16 Questionnaire in Koreans with Osteoporosis
por: Lee, Jung Sub, et al.
Publicado: (2016)

Changes in fecal metabolic and lipidomic features by anti-TNF treatment and prediction of clinical remission in patients with ulcerative colitis
por: Kim, Seok-Young, et al.
Publicado: (2023)

High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis
por: Moon, Dong-Hyuk, et al.
Publicado: (2023)

Development of a Clinical and Genetic Prediction Model for Early Intestinal Resection in Patients with Crohn’s Disease: Results from the IMPACT Study
por: Kang, Eun Ae, et al.
Publicado: (2021)

Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Trends and risk factors of elderly-onset Crohn’s disease: A nationwide cohort study
por: Moon, Jung Min, et al.
Publicado: (2020)

Second Korean guidelines for the management of Crohn's disease
por: Park, Jae Jun, et al.
Publicado: (2017)

Anemia is associated with the risk of Crohn’s disease, not ulcerative colitis: A nationwide population-based cohort study
por: Kang, Eun Ae, et al.
Publicado: (2020)

Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence
por: Yu, Jongwook, et al.
Publicado: (2022)

Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn’s disease
por: Kim, Eun Sil, et al.
Publicado: (2023)

Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-α inhibitor
por: Chung, Keun Bum, et al.
Publicado: (2013)

Peripheral Artery Disease in Korean Patients Undergoing Percutaneous Coronary Intervention: Prevalence and Association with Coronary Artery Disease Severity
por: Kim, Eun Kyoung, et al.
Publicado: (2013)

Clinical and endoscopic characteristics of sessile serrated adenomas/polyps with dysplasia/adenocarcinoma in a Korean population: A Korean Association for the Study of Intestinal Diseases (KASID) multicenter study
por: Kim, Ki-Hyun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_btdpfdfhtlcej18i4gi1jg1dg4